Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 8.050
1.
Ugeskr Laeger ; 186(17)2024 Apr 22.
Article Da | MEDLINE | ID: mdl-38704711

Non-traumatic fractures due to seizures are an overlooked diagnostic group. It is well known that patients with generalized tonic-clonic seizures have an increased trauma risk. However, the cause of fracture is rarely due to the violent forces of muscle contractions. Usually, the primary patient examination focuses on the aetiology of the seizure, which sometimes delays the diagnosis of fractures. This is a case report of a 19-year-old woman who sustained three compression fractures of the thoracic spine due to a generalized tonic-clonic seizure, and a discussion of the diagnostic challenges in such a rare case.


Fractures, Compression , Spinal Fractures , Thoracic Vertebrae , Humans , Female , Spinal Fractures/diagnostic imaging , Spinal Fractures/complications , Spinal Fractures/diagnosis , Young Adult , Fractures, Compression/diagnostic imaging , Fractures, Compression/etiology , Fractures, Compression/diagnosis , Fractures, Compression/complications , Thoracic Vertebrae/injuries , Thoracic Vertebrae/diagnostic imaging , Seizures/etiology , Seizures/diagnosis , Fractures, Multiple/diagnostic imaging , Tomography, X-Ray Computed , Epilepsy, Tonic-Clonic/etiology , Epilepsy, Tonic-Clonic/diagnosis
2.
Neurology ; 102(10): e209389, 2024 May.
Article En | MEDLINE | ID: mdl-38691824

BACKGROUND AND OBJECTIVES: Many adolescents with undiagnosed focal epilepsy seek evaluation in emergency departments (EDs). Accurate history-taking is essential to prompt diagnosis and treatment. In this study, we investigated ED recognition of motor vs nonmotor seizures and its effect on management and treatment of focal epilepsy in adolescents. METHODS: This was a retrospective analysis of enrollment data from the Human Epilepsy Project (HEP), an international multi-institutional study that collected data from 34 sites between 2012 and 2017. Participants were 12 years or older, neurotypical, and within 4 months of treatment initiation for focal epilepsy. We used HEP enrollment medical records to review participants' initial diagnosis and management. RESULTS: A total of 83 adolescents were enrolled between 12 and 18 years. Fifty-eight (70%) presented to an ED before diagnosis of epilepsy. Although most ED presentations were for motor seizures (n = 52; 90%), many patients had a history of nonmotor seizures (20/52 or 38%). Adolescents with initial nonmotor seizures were less likely to present to EDs (26/44 or 59% vs 32/39 or 82%, p = 0.02), and nonmotor seizures were less likely to be correctly identified (2/6 or 33% vs 42/52 or 81%, p = 0.008). A history of initial nonmotor seizures was not recognized in any adolescent who presented for a first-lifetime motor seizure. As a result, initiation of treatment and admission from the ED was not more likely for these adolescents who met the definition of epilepsy compared with those with no seizure history. This lack of nonmotor seizure history recognition in the ED was greater than that observed in the adult group (0% vs 23%, p = 0.03) and occurred in both pediatric and nonpediatric ED settings. DISCUSSION: Our study supports growing evidence that nonmotor seizures are often undiagnosed, with many individuals coming to attention only after conversion to motor seizures. We found this treatment gap is exacerbated in the adolescent population. Our study highlights a critical need for physicians to inquire about the symptoms of nonmotor seizures, even when the presenting seizure is motor. Future interventions should focus on improving nonmotor seizure recognition for this population in EDs.


Emergency Service, Hospital , Epilepsies, Partial , Seizures , Humans , Adolescent , Emergency Service, Hospital/statistics & numerical data , Female , Male , Retrospective Studies , Seizures/diagnosis , Seizures/physiopathology , Child , Epilepsies, Partial/diagnosis , Epilepsies, Partial/physiopathology
3.
Prim Care ; 51(2): 211-232, 2024 Jun.
Article En | MEDLINE | ID: mdl-38692771

Seizures and epilepsy are common neurologic conditions that are frequently encountered in the outpatient primary care setting. An accurate diagnosis relies on a thorough clinical history and evaluation. Understanding seizure semiology and classification is crucial in conducting the initial assessment. Knowledge of common seizure triggers and provoking factors can further guide diagnostic testing and initial management. The pharmacodynamic characteristics and side effect profiles of anti-seizure medications are important considerations when deciding treatment and counseling patients, particularly those with comorbidities and in special populations such as patient of childbearing potential.


Anticonvulsants , Epilepsy , Primary Health Care , Seizures , Humans , Epilepsy/diagnosis , Epilepsy/therapy , Seizures/diagnosis , Seizures/therapy , Anticonvulsants/therapeutic use , Physicians, Primary Care , Female , Medical History Taking
6.
Sensors (Basel) ; 24(9)2024 Apr 29.
Article En | MEDLINE | ID: mdl-38732929

The treatment of epilepsy, the second most common chronic neurological disorder, is often complicated by the failure of patients to respond to medication. Treatment failure with anti-seizure medications is often due to the presence of non-epileptic seizures. Distinguishing non-epileptic from epileptic seizures requires an expensive and time-consuming analysis of electroencephalograms (EEGs) recorded in an epilepsy monitoring unit. Machine learning algorithms have been used to detect seizures from EEG, typically using EEG waveform analysis. We employed an alternative approach, using a convolutional neural network (CNN) with transfer learning using MobileNetV2 to emulate the real-world visual analysis of EEG images by epileptologists. A total of 5359 EEG waveform plot images from 107 adult subjects across two epilepsy monitoring units in separate medical facilities were divided into epileptic and non-epileptic groups for training and cross-validation of the CNN. The model achieved an accuracy of 86.9% (Area Under the Curve, AUC 0.92) at the site where training data were extracted and an accuracy of 87.3% (AUC 0.94) at the other site whose data were only used for validation. This investigation demonstrates the high accuracy achievable with CNN analysis of EEG plot images and the robustness of this approach across EEG visualization software, laying the groundwork for further subclassification of seizures using similar approaches in a clinical setting.


Electroencephalography , Epilepsy , Machine Learning , Neural Networks, Computer , Seizures , Humans , Electroencephalography/methods , Seizures/diagnosis , Seizures/physiopathology , Epilepsy/diagnosis , Epilepsy/physiopathology , Adult , Male , Algorithms , Female , Middle Aged
7.
Sensors (Basel) ; 24(9)2024 Apr 30.
Article En | MEDLINE | ID: mdl-38732969

The recent scientific literature abounds in proposals of seizure forecasting methods that exploit machine learning to automatically analyze electroencephalogram (EEG) signals. Deep learning algorithms seem to achieve a particularly remarkable performance, suggesting that the implementation of clinical devices for seizure prediction might be within reach. However, most of the research evaluated the robustness of automatic forecasting methods through randomized cross-validation techniques, while clinical applications require much more stringent validation based on patient-independent testing. In this study, we show that automatic seizure forecasting can be performed, to some extent, even on independent patients who have never been seen during the training phase, thanks to the implementation of a simple calibration pipeline that can fine-tune deep learning models, even on a single epileptic event recorded from a new patient. We evaluate our calibration procedure using two datasets containing EEG signals recorded from a large cohort of epileptic subjects, demonstrating that the forecast accuracy of deep learning methods can increase on average by more than 20%, and that performance improves systematically in all independent patients. We further show that our calibration procedure works best for deep learning models, but can also be successfully applied to machine learning algorithms based on engineered signal features. Although our method still requires at least one epileptic event per patient to calibrate the forecasting model, we conclude that focusing on realistic validation methods allows to more reliably compare different machine learning approaches for seizure prediction, enabling the implementation of robust and effective forecasting systems that can be used in daily healthcare practice.


Algorithms , Deep Learning , Electroencephalography , Seizures , Humans , Electroencephalography/methods , Seizures/diagnosis , Seizures/physiopathology , Calibration , Signal Processing, Computer-Assisted , Epilepsy/diagnosis , Epilepsy/physiopathology , Machine Learning
8.
Comput Biol Med ; 175: 108510, 2024 Jun.
Article En | MEDLINE | ID: mdl-38691913

BACKGROUND: The seizure prediction algorithms have demonstrated their potential in mitigating epilepsy risks by detecting the pre-ictal state using ongoing electroencephalogram (EEG) signals. However, most of them require high-density EEG, which is burdensome to the patients for daily monitoring. Moreover, prevailing seizure models require extensive training with significant labeled data which is very time-consuming and demanding for the epileptologists. METHOD: To address these challenges, here we propose an adaptive channel selection strategy and a semi-supervised deep learning model respectively to reduce the number of EEG channels and to limit the amount of labeled data required for accurate seizure prediction. Our channel selection module is centered on features from EEG power spectra parameterization that precisely characterize the epileptic activities to identify the seizure-associated channels for each patient. The semi-supervised model integrates generative adversarial networks and bidirectional long short-term memory networks to enhance seizure prediction. RESULTS: Our approach is evaluated on the CHB-MIT and Siena epilepsy datasets. With utilizing only 4 channels, the method demonstrates outstanding performance with an AUC of 93.15% on the CHB-MIT dataset and an AUC of 88.98% on the Siena dataset. Experimental results also demonstrate that our selection approach reduces the model parameters and training time. CONCLUSIONS: Adaptive channel selection coupled with semi-supervised learning can offer the possible bases for a light weight and computationally efficient seizure prediction system, making the daily monitoring practical to improve patients' quality of life.


Electroencephalography , Seizures , Humans , Electroencephalography/methods , Seizures/physiopathology , Seizures/diagnosis , Signal Processing, Computer-Assisted , Deep Learning , Algorithms , Databases, Factual , Epilepsy/physiopathology , Supervised Machine Learning
9.
Biomed Phys Eng Express ; 10(3)2024 Apr 26.
Article En | MEDLINE | ID: mdl-38579694

Epilepsy, a chronic non-communicable disease is characterized by repeated unprovoked seizures, which are transient episodes of abnormal electrical activity in the brain. While Electroencephalography (EEG) is considered as the gold standard for diagnosis in current clinical practice, manual inspection of EEG is time consuming and biased. This paper presents a novel hybrid 1D CNN-Bi LSTM feature fusion model for automatically detecting seizures. The proposed model leverages spatial features extracted by one dimensional convolutional neural network and temporal features extracted by bi directional long short-term memory network. Ictal and inter ictal data is first acquired from the long multichannel EEG record. The acquired data is segmented and labelled using small fixed windows. Signal features are then extracted from the segments concurrently by the parallel combination of CNN and Bi-LSTM. The spatial and temporal features thus captured are then fused to enhance classification accuracy of model. The approach is validated using benchmark CHB-MIT dataset and 5-fold cross validation which resulted in an average accuracy of 95.90%, with precision 94.78%, F1 score 95.95%. Notably model achieved average sensitivity of 97.18% with false positivity rate at 0.05/hr. The significantly lower false positivity and false negativity rates indicate that the proposed model is a promising tool for detecting seizures in epilepsy patients. The employed parallel path network benefits from memory function of Bi-LSTM and strong feature extraction capabilities of CNN. Moreover, eliminating the need for any domain transformation or additional preprocessing steps, model effectively reduces complexity and enhances efficiency, making it suitable for use by clinicians during the epilepsy diagnostic process.


Electroencephalography , Epilepsy , Neural Networks, Computer , Seizures , Humans , Electroencephalography/methods , Seizures/diagnosis , Epilepsy/diagnosis , Algorithms , Signal Processing, Computer-Assisted , Reproducibility of Results , Brain/physiopathology
10.
Article Ru | MEDLINE | ID: mdl-38676679

OBJECTIVE: To study the follow-up of adult patients with status epilepticus or a history of serial seizures, assessing the likelihood of achieving long-term remission and identifying predictors of treatment effectiveness. MATERIAL AND METHODS: The study included 280 patients divided into 137 patients with epilepsy with a series of seizures or a history of status epilepticus (group 1) and 143 patients, who had not previously received therapy and did not have a series of seizures or a history of status epilepticus (group 2). A clinical and neurological examination, analysis of medical documentation data, electroencephalography, and MRI were performed. RESULTS: After correction of therapy, remission in patients in group 1 was achieved in 21.9%, improvement in 30%, no effect was observed in 48.1%; in group 2 the indicators were 51%, 28.7%, 20.3%, respectively. The onset of epilepsy in childhood, frequent seizures, and regional epileptiform activity were associated with the lack of treatment effect. CONCLUSION: The results confirm the main role of the clinical examination in determining the prognosis of epilepsy in a particular patient. Currently available instrumental techniques have limited predictive value.


Anticonvulsants , Electroencephalography , Magnetic Resonance Imaging , Status Epilepticus , Humans , Adult , Male , Female , Follow-Up Studies , Status Epilepticus/drug therapy , Status Epilepticus/diagnosis , Status Epilepticus/physiopathology , Middle Aged , Anticonvulsants/therapeutic use , Treatment Outcome , Prognosis , Young Adult , Seizures/drug therapy , Seizures/diagnosis , Seizures/physiopathology , Remission Induction , Adolescent , Epilepsy/drug therapy , Epilepsy/diagnosis , Epilepsy/physiopathology
11.
J Psychosom Res ; 180: 111656, 2024 May.
Article En | MEDLINE | ID: mdl-38615590

OBJECTIVE: Psychogenic non-epileptic seizures (PNES) are complex clinical manifestations and misdiagnosis as status epilepticus remains high, entailing deleterious consequences for patients. Video-electroencephalography (vEEG) remains the gold-standard method for diagnosing PNES. However, time and economic constraints limit access to vEEG, and clinicians lack fast and reliable screening tools to assist in the differential diagnosis with epileptic seizures (ES). This study aimed to design and validate the PNES-DSC, a clinically based PNES diagnostic suspicion checklist with adequate sensitivity (Se) and specificity (Sp) to discriminate PNES from ES. METHODS: A cross-sectional study with 125 patients (n = 104 drug-resistant epilepsy; n = 21 PNES) admitted for a vEEG protocolised study of seizures. A preliminary PNES-DSC (16-item) was designed and used by expert raters blinded to the definitive diagnosis to evaluate the seizure video recordings for each patient. Cohen's kappa coefficient, leave-one-out cross-validation (LOOCV) and balance accuracy (BAC) comprised the main validation analysis. RESULTS: The final PNES-DSC is a 6-item checklist that requires only two to be present to confirm the suspicion of PNES. The LOOCV showed 71.4% BAC (Se = 45.2%; Sp = 97.6%) when the expert rater watched one seizure video recording and 83.4% BAC (Se = 69.6%; Sp = 97.2%) when the expert rater watched two seizure video recordings. CONCLUSION: The PNES-DSC is a straightforward checklist with adequate psychometric properties. With an integrative approach and appropriate patient history, the PNES-DSC can assist clinicians in expediting the final diagnosis of PNES when vEEG is limited. The PNES-DSC can also be used in the absence of patients, allowing clinicians to assess seizure recordings from smartphones.


Checklist , Electroencephalography , Seizures , Humans , Adult , Female , Diagnosis, Differential , Male , Cross-Sectional Studies , Seizures/diagnosis , Electroencephalography/methods , Middle Aged , Video Recording , Psychophysiologic Disorders/diagnosis , Reproducibility of Results , Young Adult , Sensitivity and Specificity , Epilepsy/diagnosis , Conversion Disorder/diagnosis , Somatoform Disorders/diagnosis
13.
Lancet Neurol ; 23(5): 511-521, 2024 May.
Article En | MEDLINE | ID: mdl-38631767

Epilepsy diagnosis is often delayed or inaccurate, exposing people to ongoing seizures and their substantial consequences until effective treatment is initiated. Important factors contributing to this problem include delayed recognition of seizure symptoms by patients and eyewitnesses; cultural, geographical, and financial barriers to seeking health care; and missed or delayed diagnosis by health-care providers. Epilepsy diagnosis involves several steps. The first step is recognition of epileptic seizures; next is classification of epilepsy type and whether an epilepsy syndrome is present; finally, the underlying epilepsy-associated comorbidities and potential causes must be identified, which differ across the lifespan. Clinical history, elicited from patients and eyewitnesses, is a fundamental component of the diagnostic pathway. Recent technological advances, including smartphone videography and genetic testing, are increasingly used in routine practice. Innovations in technology, such as artificial intelligence, could provide new possibilities for directly and indirectly detecting epilepsy and might make valuable contributions to diagnostic algorithms in the future.


Artificial Intelligence , Epilepsy , Humans , Longevity , Epilepsy/therapy , Seizures/diagnosis , Comorbidity
14.
Sci Rep ; 14(1): 8204, 2024 04 08.
Article En | MEDLINE | ID: mdl-38589379

Seizure prediction remains a challenge, with approximately 30% of patients unresponsive to conventional treatments. Addressing this issue is crucial for improving patients' quality of life, as timely intervention can mitigate the impact of seizures. In this research field, it is critical to identify the preictal interval, the transition from regular brain activity to a seizure. While previous studies have explored various Electroencephalogram (EEG) based methodologies for prediction, few have been clinically applicable. Recent studies have underlined the dynamic nature of EEG data, characterised by data changes with time, known as concept drifts, highlighting the need for automated methods to detect and adapt to these changes. In this study, we investigate the effectiveness of automatic concept drift adaptation methods in seizure prediction. Three patient-specific seizure prediction approaches with a 10-minute prediction horizon are compared: a seizure prediction algorithm incorporating a window adjustment method by optimising performance with Support Vector Machines (Backwards-Landmark Window), a seizure prediction algorithm incorporating a data-batch (seizures) selection method using a logistic regression (Seizure-batch Regression), and a seizure prediction algorithm with a dynamic integration of classifiers (Dynamic Weighted Ensemble). These methods incorporate a retraining process after each seizure and use a combination of univariate linear features and SVM classifiers. The Firing Power was used as a post-processing technique to generate alarms before seizures. These methodologies were compared with a control approach based on the typical machine learning pipeline, considering a group of 37 patients with Temporal Lobe Epilepsy from the EPILEPSIAE database. The best-performing approach (Backwards-Landmark Window) achieved results of 0.75 ± 0.33 for sensitivity and 1.03 ± 1.00 for false positive rate per hour. This new strategy performed above chance for 89% of patients with the surrogate predictor, whereas the control approach only validated 46%.


Epilepsy , Quality of Life , Humans , Seizures/diagnosis , Epilepsy/diagnosis , Electroencephalography/methods , Algorithms , Machine Learning , Support Vector Machine
15.
PLoS Comput Biol ; 20(4): e1011152, 2024 Apr.
Article En | MEDLINE | ID: mdl-38662736

Numerous physiological processes are cyclical, but sampling these processes densely enough to perform frequency decomposition and subsequent analyses can be challenging. Mathematical approaches for decomposition and reconstruction of sparsely and irregularly sampled signals are well established but have been under-utilized in physiological applications. We developed a basis pursuit denoising with polynomial detrending (BPWP) model that recovers oscillations and trends from sparse and irregularly sampled timeseries. We validated this model on a unique dataset of long-term inter-ictal epileptiform discharge (IED) rates from human hippocampus recorded with a novel investigational device with continuous local field potential sensing. IED rates have well established circadian and multiday cycles related to sleep, wakefulness, and seizure clusters. Given sparse and irregular samples of IED rates from multi-month intracranial EEG recordings from ambulatory humans, we used BPWP to compute narrowband spectral power and polynomial trend coefficients and identify IED rate cycles in three subjects. In select cases, we propose that random and irregular sampling may be leveraged for frequency decomposition of physiological signals. Trial Registration: NCT03946618.


Epilepsy , Humans , Algorithms , Computational Biology/methods , Electrocorticography/methods , Electroencephalography/methods , Epilepsy/physiopathology , Epilepsy/diagnosis , Hippocampus/physiopathology , Hippocampus/physiology , Models, Neurological , Seizures/physiopathology , Seizures/diagnosis , Signal Processing, Computer-Assisted , Female
16.
J Trop Pediatr ; 70(3)2024 04 05.
Article En | MEDLINE | ID: mdl-38670794

OBJECTIVE: This study aimed to use machine learning to evaluate the risk factors of seizures and develop a model and nomogram to predict seizures in children with coronavirus disease 2019 (COVID-19). MATERIAL AND METHODS: A total of 519 children with COVID-19 were assessed to develop predictive models using machine learning algorithms, including extreme gradient boosting (XGBoost), random forest (RF) and logistic regression (LR). The performance of the models was assessed using area under the receiver operating characteristic curve (AUC) values. Importance matrix plot and SHapley Additive exPlanations (SHAP) values were calculated to evaluate feature importance and to show the visualization results. The nomogram and clinical impact curve were used to validate the final model. RESULTS: Two hundred and seventeen children with COVID-19 had seizures. According to the AUC, the RF model performed the best. Based on the SHAP values, the top three most important variables in the RF model were neutrophil percentage, cough and fever duration. The nomogram and clinical impact curve also verified that the RF model possessed significant predictive value. CONCLUSIONS: Our research indicates that the RF model demonstrates excellent performance in predicting seizures, and our novel nomogram can facilitate clinical decision-making and potentially offer benefit for clinicians to prevent and treat seizures in children with COVID-19.


COVID-19 , Machine Learning , Nomograms , SARS-CoV-2 , Seizures , Humans , COVID-19/complications , COVID-19/diagnosis , Seizures/etiology , Seizures/diagnosis , Female , Male , Child , Child, Preschool , Risk Factors , ROC Curve , Logistic Models , Infant
17.
Epilepsy Res ; 202: 107356, 2024 May.
Article En | MEDLINE | ID: mdl-38564925

Implantable brain recording and stimulation devices apply to a broad spectrum of conditions, such as epilepsy, movement disorders and depression. For long-term monitoring and neuromodulation in epilepsy patients, future extracranial subscalp implants may offer a promising, less-invasive alternative to intracranial neurotechnologies. To inform the design and assess the safety profile of such next-generation devices, we estimated extracranial complication rates of deep brain stimulation (DBS), cranial peripheral nerve stimulation (PNS), responsive neurostimulation (RNS) and existing subscalp EEG devices (sqEEG), as proxy for future implants. Pubmed was searched systematically for DBS, PNS, RNS and sqEEG studies from 2000 to February 2024 (48 publications, 7329 patients). We identified seven categories of extracranial adverse events: infection, non-infectious cutaneous complications, lead migration, lead fracture, hardware malfunction, pain and hemato-seroma. We used cohort sizes, demographics and industry funding as metrics to assess risks of bias. An inverse variance heterogeneity model was used for pooled and subgroup meta-analysis. The pooled incidence of extracranial complications reached 14.0%, with infections (4.6%, CI 95% [3.2 - 6.2]), surgical site pain (3.2%, [0.6 - 6.4]) and lead migration (2.6%, [1.0 - 4.4]) as leading causes. Subgroup analysis showed a particularly high incidence of persisting pain following PNS (12.0%, [6.8 - 17.9]) and sqEEG (23.9%, [12.7 - 37.2]) implantation. High rates of lead migration (12.4%, [6.4 - 19.3]) were also identified in the PNS subgroup. Complication analysis of DBS, PNS, RNS and sqEEG studies provides a significant opportunity to optimize the safety profile of future implantable subscalp devices for chronic EEG monitoring. Developing such promising technologies must address the risks of infection, surgical site pain, lead migration and skin erosion. A thin and robust design, coupled to a lead-anchoring system, shall enhance the durability and utility of next-generation subscalp implants for long-term EEG monitoring and neuromodulation.


Deep Brain Stimulation , Humans , Deep Brain Stimulation/adverse effects , Deep Brain Stimulation/instrumentation , Deep Brain Stimulation/methods , Seizures/diagnosis , Electroencephalography/methods , Electroencephalography/instrumentation , Electrodes, Implanted/adverse effects
18.
Epilepsy Res ; 202: 107363, 2024 May.
Article En | MEDLINE | ID: mdl-38636407

Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is a rare autosomal recessive disorder due to a deficiency of α-aminoadipic semialdehyde dehydrogenase. This study aimed to systematically explore genotypic and phenotypic features and prognostic factors of neonatal-onset PDE. A literature search covering PubMed, Elsevier, and Web of Science was conducted from January 2006 to August 2023. We identified 56 eligible studies involving 169 patients and 334 alleles. The c.1279 G>C variant was the most common variant of neonatal-onset PDE (25.7 %). All patients were treated with pyridoxine; forty patients received dietary intervention therapy. 63.9 % of the patients were completely seizure-free; however, 68.6 % of the patients had neurodevelopmental delays. Additionally, homozygous c.1279 G>C variants were significantly associated with ventriculomegaly, abnormal white matter signal, and cysts (P<0.05). In contrast, homozygous c.1364 T>C was associated with clonic seizure (P=0.031). Pyridoxine used immediately at seizure onset was an independent protective factor for developmental delay (P=0.035; odds ratio [OR]: 3.14). Besides, pyridoxine used early in the neonatal period was a protective factor for language delay (P=0.044; OR: 4.59). In contrast, neonatal respiratory distress (P=0.001; OR: 127.44) and abnormal brain magnetic resonance imaging (P=0.049; OR: 3.64) were risk factors. Prenatal movement abnormality (P=0.041; OR: 20.56) and abnormal white matter signal (P=0.012; OR: 24.30) were risk factors for motor delay. Myoclonic seizure (P=0.023; OR: 7.13) and status epilepticus (P=0.000; OR: 9.93) were risk factors for breakthrough seizures. In conclusion, our study indicated that pyridoxine should be started immediately when unexplained neonatal seizures occur and not later than the neonatal period to prevent poor neurodevelopmental outcomes.


Epilepsy , Genotype , Phenotype , Pyridoxine , Humans , Epilepsy/genetics , Epilepsy/drug therapy , Pyridoxine/therapeutic use , Prognosis , Infant, Newborn , Aldehyde Dehydrogenase/genetics , Seizures/genetics , Seizures/diagnosis
19.
Seizure ; 117: 244-252, 2024 Apr.
Article En | MEDLINE | ID: mdl-38522169

OBJECTIVE: Strategies are needed to optimally deploy continuous EEG monitoring (CEEG) for electroencephalographic seizure (ES) identification and management due to resource limitations. We aimed to construct an efficient multi-stage prediction model guiding CEEG utilization to identify ES in critically ill children using clinical and EEG covariates. METHODS: The largest prospective single-center cohort of 1399 consecutive children undergoing CEEG was analyzed. A four-stage model was developed and trained to predict whether a subject required additional CEEG at the conclusion of each stage given their risk of ES. Logistic regression, elastic net, random forest, and CatBoost served as candidate methods for each stage and were evaluated using cross validation. An optimal multi-stage model consisting of the top-performing stage-specific models was constructed. RESULTS: When evaluated on a test set, the optimal multi-stage model achieved a cumulative specificity of 0.197 and cumulative F1 score of 0.326 while maintaining a high minimum cumulative sensitivity of 0.938. Overall, 11 % of test subjects with ES were removed from the model due to a predicted low risk of ES (falsely negative subjects). CEEG utilization would be reduced by 32 % and 47 % compared to performing 24 and 48 h of CEEG in all test subjects, respectively. We developed a web application called EEGLE (EEG Length Estimator) that enables straightforward implementation of the model. CONCLUSIONS: Application of the optimal multi-stage ES prediction model could either reduce CEEG utilization for patients at lower risk of ES or promote CEEG resource reallocation to patients at higher risk for ES.


Critical Illness , Electroencephalography , Seizures , Humans , Electroencephalography/methods , Electroencephalography/standards , Seizures/diagnosis , Seizures/physiopathology , Child , Male , Female , Child, Preschool , Infant , Prospective Studies , Adolescent , Neurophysiological Monitoring/methods
20.
Epilepsy Res ; 202: 107354, 2024 May.
Article En | MEDLINE | ID: mdl-38518433

OBJECTIVE: In this study, we present the electroclinical features and outcomes of 92 patients with epileptic spasms (ES) in clusters without modified or classical hypsarrhythmia that started in either in infancy or in childhood; we compared both groups in terms of electroclinical features, etiology, treatment, evolution, and outcome. METHODS: Between June 2000 and July 2022, 92 patients met the electroclinical diagnostic criteria of ES in clusters without hypsarrhythmia. Patients with ES associated with other epileptic encephalopathies including West Syndrome, as well as those with the specific etiology of ES and developmental and epileptic encephalopathy associated with CDKL5 were excluded. RESULTS: The patients were divided into two groups based on the age at ES onset: those with ES onset before (Group 1) and those with ES onset after 2 years of age (Group 2). The features of ES and the type of associated seizures before and after ES onset, as well as the interictal and ictal EEG and electromyography findings were similar in both groups. The etiologies were mainly structural (40.2%), genetic (11.9%), and unknown (44.6%) in majority of the patients in both groups. Thirty-one patients were seizure-free, while in the remaining patients the seizures continued. Nine patients (9.8%) with unilateral structural lesions underwent surgery with good results. The neurological abnormalities and developmental findings prior to ES onset depended on the underlying etiology. CONCLUSION: Our series of patients may represent a well-defined epileptic syndrome or type of epilepsy with onset in infancy or childhood characterized by ES in clusters without hypsarrhythmia associated with focal and generalized seizures and EEG paroxysms without neurological deterioration.


Electroencephalography , Epileptic Syndromes , Spasms, Infantile , Humans , Male , Female , Infant , Electroencephalography/methods , Child, Preschool , Spasms, Infantile/physiopathology , Spasms, Infantile/diagnosis , Spasms, Infantile/complications , Epileptic Syndromes/diagnosis , Epileptic Syndromes/physiopathology , Epileptic Syndromes/complications , Child , Age of Onset , Epilepsy/physiopathology , Epilepsy/diagnosis , Epilepsy/complications , Retrospective Studies , Seizures/physiopathology , Seizures/diagnosis
...